Urological function and dysfunction in aging: Diagnosis and treatment

AGS Beers Criteria® Update Expert Panel, 2019, American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults, J Am Geriatr Soc, 67, 674, 10.1111/jgs.15767 Andersson, 2011, Antimuscarinic mechanisms and the overactive detrusor: an update, Eur Urol, 59, 377, 10.1016/j.eururo.2010.11.040 Andersson, 2009, Pharmacological treatment of overactive bladder: report from the international consultation on incontinence, Curr Opin Urol, 19, 380, 10.1097/MOU.0b013e32832ce8a4 Badalian, 2010, Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey, Obstet Gynecol, 115, 795, 10.1097/AOG.0b013e3181d34806 Borson, 2003, The mini-cog as a screen for dementia: validation in a population-based sample, J Am Geriatr Soc, 51, 1451, 10.1046/j.1532-5415.2003.51465.x Burgio, 1998, Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial, JAMA, 280, 1995, 10.1001/jama.280.23.1995 Burgio, 2002, Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial, JAMA, 288, 2293, 10.1001/jama.288.18.2293 Burgio, 2011, Behavioral versus drug treatment for overactive bladder in men: the male overactive bladder treatment in veterans (MOTIVE) trial, J Am Geriatr Soc, 59, 2209, 10.1111/j.1532-5415.2011.03724.x Cardozo, 1998, Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee, Obstet Gynecol, 92, 722 Christmas, 1988, Role of subcutaneous apomorphine in parkinsonian voiding dysfunction, Lancet, 2, 1451, 10.1016/S0140-6736(88)90932-4 Colosimo, 2010, Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study, J Neurol, 257, 5, 10.1007/s00415-009-5255-7 Dowling, 2005, Melatonin for sleep disturbances in Parkinson's disease, Sleep Med, 6, 459, 10.1016/j.sleep.2005.04.004 Drake, 2004, Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement, J Urol, 171, 1199, 10.1097/01.ju.0000110442.47593.ea DuBeau, 2010, Incontinence in the frail elderly: report from the 4th international consultation on incontinence, Neurourol Urodyn, 29, 165, 10.1002/nau.20842 Falconer, 1994, Predicting stroke inpatient rehabilitation outcome using a classification tree approach, Arch Phys Med Rehabil, 75, 619, 10.1016/0003-9993(94)90182-1 Fine, 2008, Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications, J Am Osteopath Assoc, 108, 333 Giannantoni, 2011, Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder, J Urol, 186, 960, 10.1016/j.juro.2011.04.071 Gill, 2005, A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs, Arch Intern Med, 165, 808, 10.1001/archinte.165.7.808 Gilman, 1998, Consensus statement on the diagnosis of multiple system atrophy, Clin Auton Res, 8, 359, 10.1007/BF02309628 Institute of Medicine, Food and Nutrition Board, 2010 Johnson, 2016, Pilot results from a randomized trial in men comparing alpha-adrenergic antagonist versus behavior and exercise for nocturia and sleep, Clin Ther, 38, 2394, 10.1016/j.clinthera.2016.10.001 Johnson, 2001, Urinary incontinence treatment preferences in long-term care, J Am Geriatr Soc, 49, 710, 10.1046/j.1532-5415.2001.49146.x Johnson, 2005, Effects of behavioral and drug therapy on nocturia in older incontinent women, J Am Geriatr Soc, 53, 846, 10.1111/j.1532-5415.2005.53260.x Kabay, 2009, Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease, Neurourol Urodyn, 28, 62, 10.1002/nau.20593 Kaplan, 2006, Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial, JAMA, 296, 2319, 10.1001/jama.296.19.2319 Kay, 2005, Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients, J Am Geriatr Soc, 53, 2195, 10.1111/j.1532-5415.2005.00537.x Kay, 2006, Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects, Eur Urol, 50, 317, 10.1016/j.eururo.2006.03.057 Kincade, 2007, Randomized clinical trial of efficacy of self-monitoring techniques to treat urinary incontinence in women, Neurourol Urodyn, 26, 507, 10.1002/nau.20413 McConnell, 2003, The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia, N Engl J Med, 349, 2387, 10.1056/NEJMoa030656 Medeiros, 2007, Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease, J Neurol, 254, 459, 10.1007/s00415-006-0390-x Nicolle, 2003, Asymptomatic bacteriuria when to screen and when to treat, Infect Dis Clin North Am, 17, 367, 10.1016/S0891-5520(03)00008-4 Nicolle, 2009, Urinary tract infections in the elderly, Clin Geriatr Med, 25, 423, 10.1016/j.cger.2009.04.005 Orasanu, 2013, The use of botulinum toxin for the treatment of overactive bladder syndrome, Indian J Urol, 29, 2, 10.4103/0970-1591.109975 Ouslander, 1995, Predictors of successful prompted voiding among incontinent nursing home residents, JAMA, 273, 1366, 10.1001/jama.1995.03520410060027 Paviour, 2005, Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis, Mov Disord, 20, 1425, 10.1002/mds.20584 Podsiadlo, 1991, The timed “Up & Go”: a test of basic functional mobility for frail elderly persons, J Am Geriatr Soc, 39, 142, 10.1111/j.1532-5415.1991.tb01616.x Ponzone, 2005, Vaginal oestrogen therapy after breast cancer: is it safe?, Eur J Cancer, 41, 2673, 10.1016/j.ejca.2005.07.015 Ransmayr, 2008, Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease, Neurology, 70, 299, 10.1212/01.wnl.0000296826.61499.26 Roth, 2009, Benign prostatic obstruction and Parkinson's disease—should transurethral resection of the prostate be avoided?, J Urol, 181, 2209, 10.1016/j.juro.2009.01.049 Sakakibara, 2016, A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders, Neurourol Urodyn, 35, 551, 10.1002/nau.22764 Sarma, 2012, Benign prostatic hyperplasia and lower urinary tract symptoms, N Engl J Med, 367, 248, 10.1056/NEJMcp1106637 Shamliyan, 2012, Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review, Ann Intern Med, 156, 861, 10.7326/0003-4819-156-12-201206190-00436 Staskin, 1988, Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control, J Urol, 140, 117, 10.1016/S0022-5347(17)41501-1 Stocchi, 1998, Sleep disorders in Parkinson's disease, J Neurol, 245, S15, 10.1007/PL00007731 Uchiyama, 2003, Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon, Mov Disord, 18, 573, 10.1002/mds.10403 Vaughan, 2009, A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results, BJU Int, 104, 69, 10.1111/j.1464-410X.2009.08353.x Vaughan, 2011, Vitamin D and lower urinary tract symptoms among US men: results from the 2005-2006 National Health and Nutrition Examination Survey, Urology, 78, 1292, 10.1016/j.urology.2011.07.1415 Vaughan, 2016, Vitamin D and incident urinary incontinence in older adults, Eur J Clin Nutr, 70, 987, 10.1038/ejcn.2016.20 Vaughan, 2019, Behavioral therapy for urinary symptoms in Parkinson's disease: a randomized clinical trial, Neurourol Urodyn, 38, 1737, 10.1002/nau.24052 Wagg, 2015, Urinary incontinence in frail elderly persons: report from the 5th international consultation on incontinence, Neurourol Urodyn, 34, 398, 10.1002/nau.22602 Zesiewicz, 2015, Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease, Parkinsonism Relat Disord, 21, 514, 10.1016/j.parkreldis.2015.02.025